MedTrace Logo

Trial of Early Screening Test for Pre-eclampsia and Growth Restriction

NCT03674606 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 546

Last updated 2018-09-17

No results posted yet for this study

Summary

A study of aspirin use in pregnancy to prevent high blood pressure and growth restriction of the fetus

Conditions

  • Pre-Eclampsia
  • Placenta Diseases
  • Eclampsia Preeclampsia
  • Fetal Growth Retardation
  • Foetal Growth Restriction

Interventions

DRUG

Low dose aspirin

One 75 mg aspirin dose taken daily

Sponsors & Collaborators

  • Perinatal Ireland

    collaborator OTHER

  • National Maternity Hospital, Ireland

    collaborator OTHER

  • Royal College of Surgeons, Ireland

    collaborator OTHER

  • University College Dublin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-01
Primary Completion
2016-04-13
Completion
2016-04-13

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03674606 on ClinicalTrials.gov